Caricamento...
Pirfenidone treatment in idiopathic pulmonary fibrosis: nationwide Danish results
BACKGROUND: Pirfenidone was approved by the European Medicines Agency and introduced in most European countries in 2011 for treatment of idiopathic pulmonary fibrosis (IPF). OBJECTIVE: To describe the national Danish experiences of pirfenidone treatment for IPF during 30 months with respect to targe...
Salvato in:
| Pubblicato in: | Eur Clin Respir J |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Co-Action Publishing
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5018656/ https://ncbi.nlm.nih.gov/pubmed/27616539 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3402/ecrj.v3.32608 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|